Certara, Inc. Share Price
NASDAQ: CERT | Small CapCertara, Inc. Stock Performance
Open $8.19 | Prev. Close $8.13 | Circuit Range N/A |
Day Range $8.06 - $8.29 | Year Range $4.45 - $13.88 | Volume 1,91,973 |
Average Traded $8.19 |
Certara, Inc. Share Price Today
As of 10 August 2026, Certara, Inc.'s share price is $8.19. The stock opened at $8.19, compared to its previous close of $8.13. During today's trading session, Certara, Inc.'s share price traded between $8.06 and $8.29, with an average price of $8.17. Over the past 52 weeks, the stock has recorded a high of $13.88 and a low of $4.45. In terms of performance, Certara, Inc.'s share price has risen by 15.51% over the last six months and is down 24.45% on a year-on-year basis.
Certara, Inc. Share Price Chart
Certara, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.31B | PE Ratio (TTM) -819.00 | Dividend Yield N/A |
EPS (TTM) $-0.01 | Revenue (TTM) $418.84M | Return On Equity (TTM) -0.15% |
Profit Margin -0.38% | Debt to Equity 0.14 | Quarterly Earnings Growth YoY 211.23% |
Certara, Inc. Quarterly Profit & Loss
All figures in USD
Certara, Inc. Annual Profit & Loss
All figures in USD
About Certara, Inc.
Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. The company also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix Hosted, which offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration, which supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform for drug discovery teams and their external collaborators; Certara D360 software, a scientific informatics system for small molecule and biologics discovery research; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and assembles regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.
Certara, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $8.34 | $8.19 | +0.99% |
Jul 2026 | $6.86 | $8.11 | +24.18% |
Jun 2026 | $5.83 | $6.53 | +12.30% |
May 2026 | $6.13 | $5.82 | -5.14% |
Apr 2026 | $5.77 | $6.13 | +7.73% |
Mar 2026 | $6.96 | $5.69 | -19.75% |
Feb 2026 | $8.71 | $7.09 | -19.39% |
Jan 2026 | $8.97 | $8.79 | -0.11% |
Dec 2025 | $8.97 | $8.80 | -3.77% |
Nov 2025 | $11.62 | $9.15 | -21.36% |
Oct 2025 | $12.25 | $11.63 | -4.83% |
Sep 2025 | $10.64 | $12.22 | +12.78% |